Table of Content

1 Human Insulin Market Overview
1.1 Human Insulin Product Overview
1.2 Human Insulin Market Segment by Type
1.2.1 Insulin Analogs and Biosimilars
1.2.2 Human Insulin Biologics
1.3 Global Human Insulin Market Size by Type
1.3.1 Global Human Insulin Market Size Overview by Type (2018-2034)
1.3.2 Global Human Insulin Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Insulin Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Insulin Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Insulin Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Insulin Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Insulin Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Insulin Sales Breakdown by Type (2018-2024)
2 Global Human Insulin Market Competition by Company
2.1 Global Top Players by Human Insulin Sales (2018-2024)
2.2 Global Top Players by Human Insulin Revenue (2018-2024)
2.3 Global Top Players by Human Insulin Price (2018-2024)
2.4 Global Top Manufacturers Human Insulin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Insulin Market Competitive Situation and Trends
2.5.1 Human Insulin Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Insulin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Insulin as of 2022)
2.7 Date of Key Manufacturers Enter into Human Insulin Market
2.8 Key Manufacturers Human Insulin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Insulin Status and Outlook by Region
3.1 Global Human Insulin Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Human Insulin Historic Market Size by Region
3.2.1 Global Human Insulin Sales in Volume by Region (2018-2024)
3.2.2 Global Human Insulin Sales in Value by Region (2018-2024)
3.2.3 Global Human Insulin Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Insulin Forecasted Market Size by Region
3.3.1 Global Human Insulin Sales in Volume by Region (2024-2034)
3.3.2 Global Human Insulin Sales in Value by Region (2024-2034)
3.3.3 Global Human Insulin Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Insulin by Application
4.1 Human Insulin Market Segment by Application
4.1.1 Short Acting
4.1.2 Intermediate Acting
4.1.3 Long Acting
4.1.4 Pre-Mix Insulin
4.2 Global Human Insulin Market Size by Application
4.2.1 Global Human Insulin Market Size Overview by Application (2018-2034)
4.2.2 Global Human Insulin Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Insulin Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Insulin Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Insulin Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Insulin Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Insulin Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Insulin Sales Breakdown by Application (2018-2024)
5 North America Human Insulin by Country
5.1 North America Human Insulin Historic Market Size by Country
5.1.1 North America Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Human Insulin Sales in Volume by Country (2018-2024)
5.1.3 North America Human Insulin Sales in Value by Country (2018-2024)
5.2 North America Human Insulin Forecasted Market Size by Country
5.2.1 North America Human Insulin Sales in Volume by Country (2024-2034)
5.2.2 North America Human Insulin Sales in Value by Country (2024-2034)
6 Europe Human Insulin by Country
6.1 Europe Human Insulin Historic Market Size by Country
6.1.1 Europe Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Human Insulin Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Insulin Sales in Value by Country (2018-2024)
6.2 Europe Human Insulin Forecasted Market Size by Country
6.2.1 Europe Human Insulin Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Insulin Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Insulin by Region
7.1 Asia-Pacific Human Insulin Historic Market Size by Region
7.1.1 Asia-Pacific Human Insulin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Insulin Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Insulin Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Insulin Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Insulin Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Insulin Sales in Value by Region (2024-2034)
8 Latin America Human Insulin by Country
8.1 Latin America Human Insulin Historic Market Size by Country
8.1.1 Latin America Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Human Insulin Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Insulin Sales in Value by Country (2018-2024)
8.2 Latin America Human Insulin Forecasted Market Size by Country
8.2.1 Latin America Human Insulin Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Insulin Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Insulin by Country
9.1 Middle East and Africa Human Insulin Historic Market Size by Country
9.1.1 Middle East and Africa Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Insulin Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Insulin Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Insulin Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Insulin Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Insulin Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 B. Braun
10.1.1 B. Braun Company Information
10.1.2 B. Braun Introduction and Business Overview
10.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.1.4 B. Braun Human Insulin Products Offered
10.1.5 B. Braun Recent Development
10.2 Becton, Dickinson
10.2.1 Becton, Dickinson Company Information
10.2.2 Becton, Dickinson Introduction and Business Overview
10.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Becton, Dickinson Human Insulin Products Offered
10.2.5 Becton, Dickinson Recent Development
10.3 Biocon
10.3.1 Biocon Company Information
10.3.2 Biocon Introduction and Business Overview
10.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biocon Human Insulin Products Offered
10.3.5 Biocon Recent Development
10.4 Biodel
10.4.1 Biodel Company Information
10.4.2 Biodel Introduction and Business Overview
10.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Biodel Human Insulin Products Offered
10.4.5 Biodel Recent Development
10.5 ELI Lilly
10.5.1 ELI Lilly Company Information
10.5.2 ELI Lilly Introduction and Business Overview
10.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.5.4 ELI Lilly Human Insulin Products Offered
10.5.5 ELI Lilly Recent Development
10.6 Julphar
10.6.1 Julphar Company Information
10.6.2 Julphar Introduction and Business Overview
10.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Julphar Human Insulin Products Offered
10.6.5 Julphar Recent Development
10.7 NOVO Nordisk
10.7.1 NOVO Nordisk Company Information
10.7.2 NOVO Nordisk Introduction and Business Overview
10.7.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.7.4 NOVO Nordisk Human Insulin Products Offered
10.7.5 NOVO Nordisk Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sanofi Human Insulin Products Offered
10.8.5 Sanofi Recent Development
10.9 Wockhardt
10.9.1 Wockhardt Company Information
10.9.2 Wockhardt Introduction and Business Overview
10.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Wockhardt Human Insulin Products Offered
10.9.5 Wockhardt Recent Development
10.10 Ypsomed
10.10.1 Ypsomed Company Information
10.10.2 Ypsomed Introduction and Business Overview
10.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ypsomed Human Insulin Products Offered
10.10.5 Ypsomed Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Insulin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Insulin Industrial Chain Analysis
11.4 Human Insulin Market Dynamics
11.4.1 Human Insulin Industry Trends
11.4.2 Human Insulin Market Drivers
11.4.3 Human Insulin Market Challenges
11.4.4 Human Insulin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Insulin Distributors
12.3 Human Insulin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Insulin Analogs and Biosimilars
Table 2. Major Company of Human Insulin Biologics
Table 3. Global Human Insulin Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Human Insulin Sales by Type (2018-2024) & (K Doses)
Table 5. Global Human Insulin Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Human Insulin Sales by Type (2018-2024) & (US& Million)
Table 7. Global Human Insulin Market Share in Value by Type (2018-2024)
Table 8. Global Human Insulin Price by Type (2018-2024) & (USD/Dose)
Table 9. Global Human Insulin Sales by Type (2024-2034) & (K Doses)
Table 10. Global Human Insulin Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Human Insulin Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Human Insulin Sales Market Share in Value by Type (2024-2034)
Table 13. Global Human Insulin Price by Type (2024-2034) & (USD/Dose)
Table 14. North America Human Insulin Sales by Type (2018-2024) & (K Doses)
Table 15. North America Human Insulin Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Human Insulin Sales (K Doses) by Type (2018-2024)
Table 17. Europe Human Insulin Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Human Insulin Sales (K Doses) by Type (2018-2024)
Table 19. Asia-Pacific Human Insulin Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Human Insulin Sales (K Doses) by Type (2018-2024)
Table 21. Latin America Human Insulin Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Human Insulin Sales (K Doses) by Type (2018-2024)
Table 23. Middle East and Africa Human Insulin Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Human Insulin Sales by Company (2018-2024) & (K Doses)
Table 25. Global Human Insulin Sales Share by Company (2018-2024)
Table 26. Global Human Insulin Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Human Insulin Revenue Share by Company (2018-2024)
Table 28. Global Market Human Insulin Price by Company (2018-2024) & (USD/Dose)
Table 29. Global Human Insulin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Insulin as of 2022)
Table 32. Date of Key Manufacturers Enter into Human Insulin Market
Table 33. Key Manufacturers Human Insulin Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Human Insulin Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Human Insulin Sales by Region (2018-2024) & (K Doses)
Table 37. Global Human Insulin Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Human Insulin Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Human Insulin Sales Market Share in Value by Region (2018-2024)
Table 40. Global Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 41. Global Human Insulin Sales by Region (2024-2034) & (K Doses)
Table 42. Global Human Insulin Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Human Insulin Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Human Insulin Sales Market Share in Value by Region (2024-2034)
Table 45. Global Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 46. Global Human Insulin Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Human Insulin Sales by Application (2018-2024) & (K Doses)
Table 48. Global Human Insulin Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Human Insulin Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Human Insulin Sales Market Share in Value by Application (2018-2024)
Table 51. Global Human Insulin Price by Application (2018-2024) & (USD/Dose)
Table 52. Global Human Insulin Sales by Application (2024-2034) & (K Doses)
Table 53. Global Human Insulin Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Human Insulin Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Human Insulin Sales Market Share in Value by Application (2024-2034)
Table 56. Global Human Insulin Price by Application (2024-2034) & (USD/Dose)
Table 57. North America Human Insulin Sales by Application (2018-2024) (K Doses)
Table 58. North America Human Insulin Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Human Insulin Sales by Application (2018-2024) (K Doses)
Table 60. Europe Human Insulin Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Human Insulin Sales by Application (2018-2024) (K Doses)
Table 62. Asia-Pacific Human Insulin Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Human Insulin Sales by Application (2018-2024) (K Doses)
Table 64. Latin America Human Insulin Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Human Insulin Sales by Application (2018-2024) (K Doses)
Table 66. Middle East and Africa Human Insulin Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Human Insulin Sales by Country (2018-2024) & (K Doses)
Table 68. North America Human Insulin Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Human Insulin Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Human Insulin Sales Market Share in Value by Country (2018-2024)
Table 71. North America Human Insulin Sales by Country (2024-2034) & (K Doses)
Table 72. North America Human Insulin Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Human Insulin Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Human Insulin Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Human Insulin Sales by Country (2018-2024) & (K Doses)
Table 76. Europe Human Insulin Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Human Insulin Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Human Insulin Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Human Insulin Sales by Country (2024-2034) & (K Doses)
Table 80. Europe Human Insulin Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Human Insulin Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Human Insulin Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Human Insulin Sales by Region (2018-2024) & (K Doses)
Table 84. Asia-Pacific Human Insulin Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Human Insulin Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Human Insulin Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Human Insulin Sales by Region (2024-2034) & (K Doses)
Table 88. Asia-Pacific Human Insulin Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Human Insulin Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Human Insulin Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Human Insulin Sales by Country (2018-2024) & (K Doses)
Table 92. Latin America Human Insulin Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Human Insulin Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Human Insulin Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Human Insulin Sales by Country (2024-2034) & (K Doses)
Table 96. Latin America Human Insulin Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Human Insulin Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Human Insulin Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Human Insulin Sales by Country (2018-2024) & (K Doses)
Table 100. Middle East and Africa Human Insulin Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Human Insulin Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Human Insulin Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Human Insulin Sales by Country (2024-2034) & (K Doses)
Table 104. Middle East and Africa Human Insulin Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Human Insulin Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Human Insulin Sales Market Share in Value by Country (2024-2034)
Table 107. B. Braun Company Information
Table 108. B. Braun Introduction and Business Overview
Table 109. B. Braun Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 110. B. Braun Human Insulin Product
Table 111. B. Braun Recent Development
Table 112. Becton, Dickinson Company Information
Table 113. Becton, Dickinson Introduction and Business Overview
Table 114. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 115. Becton, Dickinson Human Insulin Product
Table 116. Becton, Dickinson Recent Development
Table 117. Biocon Company Information
Table 118. Biocon Introduction and Business Overview
Table 119. Biocon Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 120. Biocon Human Insulin Product
Table 121. Biocon Recent Development
Table 122. Biodel Company Information
Table 123. Biodel Introduction and Business Overview
Table 124. Biodel Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 125. Biodel Human Insulin Product
Table 126. Biodel Recent Development
Table 127. ELI Lilly Company Information
Table 128. ELI Lilly Introduction and Business Overview
Table 129. ELI Lilly Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 130. ELI Lilly Human Insulin Product
Table 131. ELI Lilly Recent Development
Table 132. Julphar Company Information
Table 133. Julphar Introduction and Business Overview
Table 134. Julphar Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 135. Julphar Human Insulin Product
Table 136. Julphar Recent Development
Table 137. NOVO Nordisk Company Information
Table 138. NOVO Nordisk Introduction and Business Overview
Table 139. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 140. NOVO Nordisk Human Insulin Product
Table 141. NOVO Nordisk Recent Development
Table 142. Sanofi Company Information
Table 143. Sanofi Introduction and Business Overview
Table 144. Sanofi Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 145. Sanofi Human Insulin Product
Table 146. Sanofi Recent Development
Table 147. Wockhardt Company Information
Table 148. Wockhardt Introduction and Business Overview
Table 149. Wockhardt Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 150. Wockhardt Human Insulin Product
Table 151. Wockhardt Recent Development
Table 152. Ypsomed Company Information
Table 153. Ypsomed Introduction and Business Overview
Table 154. Ypsomed Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 155. Ypsomed Human Insulin Product
Table 156. Ypsomed Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Human Insulin Market Trends
Table 160. Human Insulin Market Drivers
Table 161. Human Insulin Market Challenges
Table 162. Human Insulin Market Restraints
Table 163. Human Insulin Distributors List
Table 164. Human Insulin Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Insulin Product Picture
Figure 2. Global Human Insulin Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Insulin Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Human Insulin Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Insulin Analogs and Biosimilars
Figure 6. Global Insulin Analogs and Biosimilars Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Human Insulin Biologics
Figure 8. Global Human Insulin Biologics Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Global Human Insulin Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Human Insulin Sales Market Share by Type in 2022 & 2034
Figure 11. North America Human Insulin Sales Market Share in Volume by Type in 2022
Figure 12. North America Human Insulin Sales Market Share in Value by Type in 2022
Figure 13. Europe Human Insulin Sales Market Share in Volume by Type in 2022
Figure 14. Europe Human Insulin Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Human Insulin Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Human Insulin Sales Market Share in Value by Type in 2022
Figure 17. Latin America Human Insulin Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Human Insulin Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Human Insulin Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Human Insulin Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Insulin Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Insulin Revenue in 2022
Figure 23. Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Short Acting
Figure 25. Global Short Acting Sales YoY Growth (2018-2034) & (K Doses)
Figure 26. Product Picture of Intermediate Acting
Figure 27. Global Intermediate Acting Sales YoY Growth (2018-2034) & (K Doses)
Figure 28. Product Picture of Long Acting
Figure 29. Global Long Acting Sales YoY Growth (2018-2034) & (K Doses)
Figure 30. Product Picture of Pre-Mix Insulin
Figure 31. Global Pre-Mix Insulin Sales YoY Growth (2018-2034) & (K Doses)
Figure 32. Global Human Insulin Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Human Insulin Sales Market Share by Application in 2022 & 2034
Figure 34. North America Human Insulin Sales Market Share in Volume by Application in 2022
Figure 35. North America Human Insulin Sales Market Share in Value by Application in 2022
Figure 36. Europe Human Insulin Sales Market Share in Volume by Application in 2022
Figure 37. Europe Human Insulin Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Human Insulin Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Human Insulin Sales Market Share in Value by Application in 2022
Figure 40. Latin America Human Insulin Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Human Insulin Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Human Insulin Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Human Insulin Manufacturing Cost Structure
Figure 45. Human Insulin Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed